Kala Pharmaceuticals, Inc.·4

Jun 29, 8:12 PM ET

Trachtenberg Eric 4

4 · Kala Pharmaceuticals, Inc. · Filed Jun 29, 2022

Insider Transaction Report

Form 4
Period: 2022-06-27
Trachtenberg Eric
General Counsel and Secretary
Transactions
  • Sale

    Common Stock

    2022-06-27$0.37/sh2,613$967111,203 total
Footnotes (2)
  • [F1]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
  • [F2]Includes 45,611 unvested RSUs.

Documents

1 file
  • 4
    form4-06292022_050647.xmlPrimary